Akari Therapeutics Plc ADR (AKTX)
Market Closed
15 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
8. 84
+1.56
+21.4286%
$
20.13M Market Cap
- P/E Ratio
- Div Yield
55,700 Volume
0 Eps
$ 7.28
Previous Close 
Want to track AKTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Akari Therapeutics Plc ADR (AKTX) Statistics
Valuation metrics
Market Cap 20.13M
Enterprise value 13.13M
Trailing P/E (ttm) -0.01
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.84
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.41
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 37.48K
Average volume (90 days) 51.56K
Price summary
52-Week low 3.02
52-Week high 36.76
Beta -
50-Day moving average 9.42
200-Day moving average 7.39
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:40
Last split Date 31 Mar 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.8%
Return on equity -1.47%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -17.28
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.29
Total debt (mrq) -
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 0.6%
Book value per share (mrq) 10.38
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
